SHARE
Infection Prevention And Control Market

Infection Prevention & Control - Global Market Outlook (2018-2027)

5.0 (89 reviews)
Published: May 2020 ID: SMRC19206
5.0 (89 reviews)
Published: May 2020 ID: SMRC19206

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Infection Prevention & Control Market is accounted for $139.59 billion in 2018 and is expected to reach $224.08 billion by 2027 growing at a CAGR of 5.4% during the forecast period. Some of the key factors propelling the market growth include increased adoption of contract sterilization and in-house sterilization procedures, increase in incidence of hospital acquired infections (HAIS), growing number of surgical procedures, rising number of government initiatives, and rapidly growing geriatric population. However, low level of vaccination among healthcare workers is likely to hamper the market.

Infection prevention and control is the most important and significant step in the development and maintenance of products in the medical devices, pharmaceuticals, and food industries. It is to prevent the transmission of communicable disease. For the prevention of any infection one should have the basic understanding of the infection and the risk of the infection. Infection prevention and control system includes the necessary products to prevent the cross infection from equipment, surface and skin of patient and healthcare staff.

By products & services equipment, the personal protective equipment segment is anticipated to grow at the significant rate during the forecast period. With the growth in prevention and control concerns of various health associated infections, personal protective equipment’s. To control various types of cross-infections in hospitals and clinics also there has been a growth of personal protective equipment’s market globally. Demand for better quality care in hospitals and other healthcare establishments is forcing the hospitals to invest in quality medical protective wear and other accessories has also acted as a key factor in the growth of this segment.

On the basis of geography, North America region is anticipated to have considerable market growth during the forecast period, due to rising prevalence of the nosocomial infection and stringent regulation followed by the hospitals, clinicians and care givers aligning with regulatory bodies. With the increase in the number of death due to Antibiotic-resistant infections, by contrast it is anticipated that there will be a growth in IP&C Market in the regions of North America.

Some of the key players in infection prevention & control market include Danaher Corporation, Johnson & Johnson, Becton, Dickinson, and Company, 3M Company, Baxter International, Ansell Limited, Belimed AG, Aquionics, Bemis Company Incorporated, Abbott, Braun (B.) Melsungen AG, Cantel Medical Corporation, Cardinal Health Incorporated, Covidien, Henkel, Simens, Getinge Group, Hollister, Medtronics, and CCP Industries.

Antimicrobial Drugs Covered:
• Anti-Fungal Drugs
• Vaccines
• Anti-Bacterial Drugs
• Anti-Viral Drugs

Infection Types Covered:
• Healthcare Associated Infections
• Microbial infections

Products & Services Equipment Covered:
• Infection Prevention Supplies
• Infection Prevention Equipment

End Users Covered:
• Drug Usage
• Equipment Usage

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary    
     
2 Preface    

 2.1 Abstract   
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology   
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions  
     
3 Market Trend Analysis    
 3.1 Introduction   
 3.2 Drivers   
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats   
 3.6 End User Analysis   
 3.7 Emerging Markets   
 3.8 Impact of Covid-19  
     
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry   
     
5 Global Infection Prevention & Control Market, By Antimicrobial Drugs    
 5.1 Introduction   
 5.2 Anti-Fungal Drugs   
 5.3 Vaccines   
 5.4 Anti-Bacterial Drugs   
 5.5 Anti-Viral Drugs   
     
6 Global Infection Prevention & Control Market, By Infection Type    
 6.1 Introduction   
 6.2 Healthcare Associated Infections    
  6.2.1 Community Acquired Infection  
   6.2.1.1 Community Acquired Pneumonia (CAP) 
   6.2.1.2 Methicillin Resistant Staphylococcus Aureus (MRSA) Infection 
  6.2.2 Hospital Acquired Infection  
   6.2.2.1 Surgical Site Infection  
   6.2.2.2 Ventilator Associated Pneumonia (VAP) Infection 
   6.2.2.3 Central Line Associated Bloodstream Infection (CLABSI) 
   6.2.2.4 Catheter Associated Urinary Tract Infection 
 6.3 Microbial infections   
  6.3.1 Fungal Infections  
   6.3.1.1 Cryptococcus Gatti 
   6.3.1.2 Aspergillis 
   6.3.1.3 Pneumocystis Pneumonia (PCP) 
   6.3.1.4 Dermatophytes 
   6.3.1.5 Gungal Keratitis 
   6.3.1.6 Exserohilum 
   6.3.1.7 Cladosporium 
  6.3.2 Viral Infections  
   6.3.2.1 Herpes Simplex Virus 
   6.3.2.2 Yellow Fever 
   6.3.2.3 Dengue Viruses 
   6.3.2.4 Ebola Virus 
   6.3.2.5 Junin Virus 
   6.3.2.6 KFD (Kyasanur Forest Virus) 
   6.3.2.7 Machupo Virus 
   6.3.2.8 Human Immunodeficiency Virus (HIV) 
  6.3.3 Clostridium Difficile Infections  
   6.3.3.1 Escherichia Coli Infections 
   6.3.3.2 Helicobacter Pylori 
   6.3.3.3 Salmonella 
  6.3.4 Exserohilum  
  6.3.5 Bacterial Infections  
   6.3.5.1 Mycobacterium Tuberculosis 
     
7 Global Infection Prevention & Control Market, By Products & Services Equipment     
 7.1 Introduction   
 7.2 Infection Prevention Supplies   
  7.2.1 Disinfectants  
   7.2.1.1 Surgical Disinfectants 
   7.2.1.2 Environmental Disinfectants 
   7.2.1.3 Surface Disinfectants 
   7.2.1.4 Instrument Disinfectants 
   7.2.1.5 Skin Disinfectants 
   7.2.1.6 Hand Sanitizers 
   7.2.1.7 Disinfectants Wipes 
  7.2.2 Autoclave  
   7.2.2.1 Horizontal Autoclave 
   7.2.2.2 Portable Autoclave 
   7.2.2.3 Vertical Autoclave 
  7.2.3 Personal Protective Equipment  
   7.2.3.1 Medical & Laboratory Gloves 
    7.2.3.1.1 Examination Gloves
    7.2.3.1.2 Surgical Gloves
    7.2.3.1.3 Laboratory Gloves
   7.2.3.2 Surgical Masks & Respirators 
   7.2.3.3 Surgical Foot Covers  
   7.2.3.4 Surgical Drapes 
    7.2.3.4.1 Nonwoven Drapes
    7.2.3.4.2 Plastic Drapes
    7.2.3.4.3 Woven Drapes
   7.2.3.5 Surgical Gowns 
   7.2.3.6 Patient Gowns 
   7.2.3.7 Surgical & Staff Face Masks 
   7.2.3.8 Other Personal Protective Equipment 
    7.2.3.8.1 Disposable Staff Apparel
    7.2.3.8.2 Disposable Towels & Bedding
  7.2.4 Safety-Enhanced Medical Devices  
   7.2.4.1 Safety-Enhanced Syringes 
    7.2.4.1.1 Prefillable Syringes
    7.2.4.1.2 Safety-Enhanced Clinical Syringes
   7.2.4.2 Safety-Enhanced Catheters 
    7.2.4.2.1 IV Catheters
    7.2.4.2.2 Urinary Catheters
   7.2.4.3 Safety-Enhanced Blood Collection Tubes 
  7.2.5 Sterilization Supplies  
   7.2.5.1 Sterile Containers 
   7.2.5.2 Sterilization Wrap 
   7.2.5.3 Sterilization Indicators 
  7.2.6 Medical Waste Disposal Supplies  
   7.2.6.1 Medical Waste Disposal Containers 
   7.2.6.2 Medical Waste Disposal Accessories 
 7.3 Infection Prevention Equipment   
  7.3.1 Sterilization Equipment  
   7.3.1.1 Sterilization Technologies 
    7.3.1.1.1 Filtration Sterilization
    7.3.1.1.2 Radiation Sterilization
    7.3.1.1.3 Low Temperature Sterilization
     7.3.1.1.3.1 In-House Steam Sterilization
     7.3.1.1.3.2 Ethylene Oxide (EO) Sterilization
     7.3.1.1.3.3 Gamma and e-Beam Sterilization
    7.3.1.1.4 Wet/Stream Sterilization
    7.3.1.1.5 Dry Heat Sterilization
    7.3.1.1.6 Contract Sterilization Services
  7.3.2 Washing/Disinfecting Equipment  
  7.3.3 Endoscope Reprocessors  
  7.3.4 Other Infection Prevention Equipment  
   7.3.4.1 Infectious Waste Receptacles 
   7.3.4.2 Infectious Waste Processing Units 
     
8 Global Infection Prevention & Control Market, By End User    
 8.1 Introduction   
 8.2 Drug Usage   
  8.2.1 Individuals & Patients  
  8.2.2 Nursing & Senior care Centers  
 8.3 Equipment Usage    
  8.3.1 Medical Laboratories  
  8.3.2 Manufacturing Units  
   8.3.2.1 Pharmaceuticals 
   8.3.2.2 Medical Devices 
   8.3.2.3 Food & Beverages Industry 
  8.3.3 Hospitals & Clinics  
  8.3.4 Life Science Industry  
     
9 Global Infection Prevention & Control Market, By Geography    
 9.1 Introduction   
 9.2 North America   
  9.2.1 US  
  9.2.2 Canada  
  9.2.3 Mexico  
 9.3 Europe   
  9.3.1 Germany  
  9.3.2 UK  
  9.3.3 Italy  
  9.3.4 France  
  9.3.5 Spain  
  9.3.6 Rest of Europe  
 9.4 Asia Pacific   
  9.4.1 Japan  
  9.4.2 China  
  9.4.3 India  
  9.4.4 Australia  
  9.4.5 New Zealand  
  9.4.6 South Korea  
  9.4.7 Rest of Asia Pacific  
 9.5 South America   
  9.5.1 Argentina  
  9.5.2 Brazil  
  9.5.3 Chile  
  9.5.4 Rest of South America  
 9.6 Middle East & Africa   
  9.6.1 Saudi Arabia  
  9.6.2 UAE  
  9.6.3 Qatar  
  9.6.4 South Africa  
  9.6.5 Rest of Middle East & Africa  
     
10 Key Developments    
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures   
 10.2 Acquisitions & Mergers   
 10.3 New Product Launch   
 10.4 Expansions   
 10.5 Other Key Strategies   
     
11 Company Profiling    
 11.1 Danaher Corporation   
 11.2 Johnson & Johnson   
 11.3 Becton, Dickinson, and Company   
 11.4 3M Company   
 11.5 Baxter International   
 11.6 Ansell Limited   
 11.7 Belimed AG   
 11.8 Aquionics   
 11.9 Bemis Company Incorporated   
 11.10 Abbott   
 11.11 Braun (B.) Melsungen AG   
 11.12 Cantel Medical Corporation   
 11.13 Cardinal Health Incorporated   
 11.14 Covidien   
 11.15 Henkel   
 11.16 Simens   
 11.17 Getinge Group   
 11.18 Hollister   
 11.19 Medtronics   
 11.20 CCP Industries  


List of Tables     
1 Global Infection Prevention & Control Market Outlook, By Region (2017-2027) ($MN)    
2 Global Infection Prevention & Control Market Outlook, By Antimicrobial Drugs (2017-2027) ($MN)    
3 Global Infection Prevention & Control Market Outlook, By Anti-Fungal Drugs (2017-2027) ($MN)    
4 Global Infection Prevention & Control Market Outlook, By Vaccines (2017-2027) ($MN)    
5 Global Infection Prevention & Control Market Outlook, By Anti-Bacterial Drugs (2017-2027) ($MN)    
6 Global Infection Prevention & Control Market Outlook, By Anti-Viral Drugs (2017-2027) ($MN)    
7 Global Infection Prevention & Control Market Outlook, By Infection Type (2017-2027) ($MN)    
8 Global Infection Prevention & Control Market Outlook, By Healthcare Associated Infections (2017-2027) ($MN)    
9 Global Infection Prevention & Control Market Outlook, By Community Acquired Infection (2017-2027) ($MN)    
10 Global Infection Prevention & Control Market Outlook, By Hospital Acquired Infection (2017-2027) ($MN)    
11 Global Infection Prevention & Control Market Outlook, By Microbial infections (2017-2027) ($MN)    
12 Global Infection Prevention & Control Market Outlook, By Fungal Infections (2017-2027) ($MN)    
13 Global Infection Prevention & Control Market Outlook, By Viral Infections (2017-2027) ($MN)    
14 Global Infection Prevention & Control Market Outlook, By Clostridium Difficile Infections (2017-2027) ($MN)    
15 Global Infection Prevention & Control Market Outlook, By Exserohilum (2017-2027) ($MN)    
16 Global Infection Prevention & Control Market Outlook, By Bacterial Infections (2017-2027) ($MN)    
17 Global Infection Prevention & Control Market Outlook, By Products & Services Equipment  (2017-2027) ($MN)    
18 Global Infection Prevention & Control Market Outlook, By Infection Prevention Supplies (2017-2027) ($MN)    
19 Global Infection Prevention & Control Market Outlook, By Disinfectants (2017-2027) ($MN)    
20 Global Infection Prevention & Control Market Outlook, By Autoclave (2017-2027) ($MN)    
21 Global Infection Prevention & Control Market Outlook, By Protective Apparel & Textiles (2017-2027) ($MN)    
22 Global Infection Prevention & Control Market Outlook, By Safety-Enhanced Medical Devices (2017-2027) ($MN)    
23 Global Infection Prevention & Control Market Outlook, By Sterilization Supplies (2017-2027) ($MN)    
24 Global Infection Prevention & Control Market Outlook, By Medical Waste Disposal Supplies (2017-2027) ($MN)    
25 Global Infection Prevention & Control Market Outlook, By Infection Prevention Equipment (2017-2027) ($MN)    
26 Global Infection Prevention & Control Market Outlook, By Sterilization Equipment (2017-2027) ($MN)    
27 Global Infection Prevention & Control Market Outlook, By Washing/Disinfecting Equipment (2017-2027) ($MN)    
28 Global Infection Prevention & Control Market Outlook, By Endoscope Reprocessors (2017-2027) ($MN)    
29 Global Infection Prevention & Control Market Outlook, By Other Infection Prevention Equipment (2017-2027) ($MN)    
30 Global Infection Prevention & Control Market Outlook, By End User (2017-2027) ($MN)    
31 Global Infection Prevention & Control Market Outlook, By Drug Usage (2017-2027) ($MN)    
32 Global Infection Prevention & Control Market Outlook, By Individuals & Patients (2017-2027) ($MN)    
33 Global Infection Prevention & Control Market Outlook, By Nursing & Senior care Centers (2017-2027) ($MN)    
34 Global Infection Prevention & Control Market Outlook, By Equipment Usage (2017-2027) ($MN)    
35 Global Infection Prevention & Control Market Outlook, By Medical Laboratories (2017-2027) ($MN)    
36 Global Infection Prevention & Control Market Outlook, By Manufacturing Units (2017-2027) ($MN)    
37 Global Infection Prevention & Control Market Outlook, By Hospitals & Clinics (2017-2027) ($MN)    
38 Global Infection Prevention & Control Market Outlook, By Life Science Industry (2017-2027) ($MN)    
     
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.     

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials